Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy

Muscle and Nerve

Volumn 23, Issue 9, 2000, Pages 1316-1334

  Argov, Zohar ^a,b   Lfberg, Mervi ^a,c   Arnold, Douglas L ^a  

^a MCGILL UNIVERSITY   (Canada)

^b Department of Neurology ^*  (Israel)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Mitochondrial myopathies; Muscle; Muscular diseases; Nuclear magnetic resonance; Phosphorus

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; PHOSPHATE; PHOSPHORUS 31;

CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; EXERCISE TOLERANCE; FIBROMYALGIA; GLYCOLYSIS; HUMAN; MALIGNANT HYPERTHERMIA; METABOLIC DISORDER; MITOCHONDRIAL MYOPATHY; MUSCLE DISEASE; MUSCLE FATIGUE; MUSCLE METABOLISM; MUSCULAR DYSTROPHY; MYOSITIS; PATIENT MONITORING; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; REVIEW;

ENERGY METABOLISM; EXERCISE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MUSCULAR DISEASES; PHOSPHORUS;

EID: 0033822249     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4598(200009)23:9<1316::AID-MUS2>3.0.CO;2-I     Document Type: Review

References (166)

1. Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders
2. Phosphorus magnetic resonance spectroscopy of partially blocked muscle glycolysis. An in vivo study of phosphoglycerate mutase deficiency
3. Muscle energy metabolism in McArdle's syndrome by in vivo phosphorus magnetic resonance spectroscopy
4. Treatment of mitochondrial myopathy due to complex III deficiency with vitamins K3 and C: A 31P-NMR follow-up study
5. Muscle energy metabolism in human phosphofructokinase deficiency as recorded by 31P nuclear magnetic resonance spectroscopy
6. Bioenergetic heterogeneity of human mitochondrial myopathies: Phosphorus magnetic resonance spectroscopy study
7. Phosphorus magnetic resonance spectroscopy in nutritional research
8. ADP recovery after a brief ischemic exercise in normal and diseased human muscle - A 31P MRS study
9. Muscle high-energy phosphates in central nervous system disorders. The phosphorus MRS experience
10. Abnormal oxidative metabolism in exercise intolerance of undetermined origin
11. Effects of thyroid hormones on skeletal muscle bioenergetics. In vivo phosphorus-31 magnetic resonance spectroscopy study of humans and rats
12. Intracellular phosphates in inclusion body myositis - A 31P magnetic resonance spectroscopy study
13. Excessive intracellular acidosis of skeletal muscle on exercise in a patient with a post-viral exhaustion/fatigue syndrome. A 31P nuclear magnetic resonance study
14. Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P NMR
15. Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy
16. Regulation of oxidative phosphorylation in the mammalian cell
17. The genetics of malignant hyperthermia
18. Muscle energy metabolism in female DMD/BMD carriers: A 32P-MR spectroscopy study
19. 31P-NMR spectroscopy of skeletal muscle in Becker dystrophy and DMD/BMD carriers. Altered rate of phosphate transport
20. Skeletal muscle metabolism in myotonic dystrophy A 31P magnetic resonance spectroscopy study
21. Heterogeneity of metabolic response to muscular exercise in humans. New criteria of invariance defined by in vivo phosphorus-31 NMR spectroscopy
22. Pi trapping in glycogenolytic pathway can explain transient Pi disappearance during recovery from muscular exercise. A 31P NMR study in the human
23. 31-P NMR characterization of the metabolic anomalies associated with the lack of glycogen phosphorylase activity in human forearm muscle
24. 31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies
25. Combined electromyography-31P-magnetic resonance spectroscopy study of human muscle fatigue during static contraction
26. 31 Phosphorus magnetic resonance spectroscopy characterization of muscular metabolic anomalies in patients with malignant hyperthermia: Application to diagnosis
27. Magnetic resonance spectroscopy and histological study of tubular aggregates in a familial myopathy
28. 31P-MRS of quadriceps reveals quantitative differences between sprinters and long-distance runners
29. Individual variation in contractile cost and recovery in a human skeletal muscle
30. McArdle's disease heterozygotes. Metabolic adaptation assessed using 31P-nuclear magnetic resonance
31. Noninvasive phi measurements of human tissue using 31P-NMR
32. ATP production rates as a function of force level in the human gastrocnemius/soleus using 31P MRS
33. The metabolic basis of recovery after fatiguing exercise of human muscle
34. 31P MRS studies of exercising human muscle at high temporal resolution
35. The metabolic causes of slow relaxation in fatigued human skeletal muscle
36. Changes in force and intracellular metabolites during fatigue of human skeletal muscle
37. NMR monitoring of the energy status of skeletal muscle during hemodialysis using acetate
38. 31P NMR studies of control of mitochondrial function in phosphofruc-tokinase-deficient human skeletal muscle
39. Control of oxidative metabolism and oxygen delivery in human skeletal muscle: A steady-state analysis of the work/energy cost transfer function
40. Multiple controls of oxidative metabolism in living tissues as studied by phosphorus magnetic resonance
41. Physical deconditioning may be a mechanism for the skeletal muscle energy phosphate metabolism abnormalities in chronic heart failure
42. Fitting cytosolic ADP recover after exercise with a step response function
43. Evaluation of muscle oxidative potential by 31P-MRS during incremental exercise in old and young humans
44. Effect of amino acid administration on uremic muscle metabolism: A 31P-spectroscopy study
45. Impairment of muscle mitochondrial oxidative metabolism in McArdle's disease
46. Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders
47. Phosphorus NMR spectroscopy study of muscular enzyme deficiencies involving glycogenolysis and glycolysis
48. Clinical use of nuclear magnetic resonance in the investigation of myopathy
49. 31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle
50. Normalized metabolic stress for 31P-MR spectroscopy studies of human skeletal muscle: MVC vs. muscle volume
51. Examination of a myopathy of phosphorus nuclear magnetic resonance
52. The discrimination of different muscle-group-work rates in the calf during plantar flexion
53. Metabolic myopathy in canine muscle-type phosphofructokinase deficiency
54. Phosphorus magnetic resonance spectroscopy in the evaluation of mitochondrial myopathies: Results of a 6-month therapy study with coenzyme Q
55. 31P NMR saturation transfer study of the creatine kinase reaction in human skeletal muscle at rest and during exercise
56. Muscle energy metabolism in Duchenne dystrophy studied by 31P-NMR: Controlled trials show no effect of allopurinol or ribose
57. On the noninvasive measurement of intracellular free magnesium by 31P MR spectroscopy
58. Muscular sufficiency, serum protein, enzymes and bioenergetic studies (31-phosphorus magnetic resonance spectroscopy) in chronic malnutrition
59. 2+ in intact frog skeletal muscle
60. Effect of hypothyroidism on phosphorus metabolism in muscle and liver: In vivo P-31 MR spectroscopy study
61. Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency
62. Thyroid hormone concentrations and muscle metabolism in amenorrheic and eumenorrheic athletes
63. 2 availability
64. A mitochondrial encephalomyopathy. A combined 31P magnetic resonance and biochemical investigation
65. Biochemical and genetic studies in a family with mitochondrial myopathy
66. Human muscle performance and PCr hydrolysis with varied inspired oxygen fractions: A 31P-MRS study
67. Kinetics of post-exercise phosphate transport in human skeletal muscle: An in vivo 31P-MR spectroscopy study
68. In vivo assessment of mitochondrial functionality in human gastrocnemius muscle by 31P MRS. The role of pH in the evaluation of phosphocreatine and inorganic phosphate recoveries from exercise
69. Non-invasive quantitative 31P MRS assay of mitochondrial function in skeletal muscle in situ
70. Improved energy kinetics following high protein diet in McArdle's syndrome. A 31P magnetic resonance spectroscopy study
71. Splitting of the phosphate peak in exercising muscle is due to macroscopic not microscopic heterogeneity
72. Increased incidence of a resonance in the phosphodiester region of 31P nuclear magnetic resonance spectra in the skeletal muscle of fibromyalgia patients
73. Energetic metabolism in hypothyroid skeletal muscle, as studied by phosphorus magnetic resonance spectroscopy
74. Quantitative interpretation of bioenergetic data from 31P and 1H magnetic resonance spectroscopic studies of skeletal muscle: An analytical review
75. Cellular energetics of dystrophic muscle
76. Quantitative analysis by 31P magnetic resonance spectroscopy of abnormal mitochondrial oxidation in skeletal muscle during recovery from exercise
77. Comparisons of ATP turnover in human muscle during ischemic and aerobic exercise using 31P magnetic resonance spectroscopy
78. Proton efflux in human skeletal muscle during recovery from exercise
79. Metabolic effects of training in humans: A 31P-MRS study
80. Phases of metabolism during progressive exercise to fatigue in human skeletal muscle
81. Postexercise phosphocreatine resynthesis is slowed in multiple sclerosis
82. Central basis of muscle fatigue in chronic fatigue syndrome
83. Creatine monohydrate in mitochondrial diseases: A double blind, placebo-controlled, cross-over study in 16 patients with chronic progressive external ophthalmoplegia or mitochondrial myopathy
84. New research on muscular function: NMR spectroscopy. Application to malignant hyperthermia
85. Detection of peranesthetic malignant hyperthermia by muscle contracture tests and NMR spectroscopy
86. Mitochondrial encephalomyopathy: Correlation of P-31 exercise MR spectroscopy with clinical findings
87. 31P nuclear magnetic resonance
88. Mammalian skeletal muscle fibers distinguished by contents of phosphocreatine, ATP, and Pi
89. Heterogeneity in chronic fatigue syndrome: Evidence from magnetic resonance spectroscopy of muscle
90. Muscle fatigue in McArdle's disease studied by 31P-NMR: Effect of glucose infusion
91. Reduced cytosolic acidification during exercise suggests defective glycolytic activity in skeletal muscle of patients with Becker muscular dystrophy. An in vivo 31P magnetic resonance spectroscopy study
92. Correlative MR imaging and 31P-MR spectroscopy study in sarcoglycan deficient limb girdle muscular dystrophy
93. Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by 31P-magnetic resonance spectroscopy
94. In vivo skeletal muscle mitochondrial function in Leber's hereditary optic neuropathy assessed by 31P magnetic resonance spectroscopy
95. An evaluation of the effect of fasting on the exercise-induced changes in pH and Pi/PCr from skeletal muscle
96. Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia
97. P-31 magnetic resonance spectroscopy demonstrates unaltered muscle energy utilization in polymyalgia rheumatica
98. Gender modulates the energy cost of muscle contraction in untrained healthy subjects. A 31P magnetic resonance spectroscopy analysis
99. In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease
100. Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease
101. Detection of muscle injury in humans with 31-P magnetic resonance spectroscopy
102. Relationships between in vivo and in vitro measurements of metabolism in young and old human calf muscles
103. Muscle metabolism in older subjects using 31P magnetic resonance spectroscopy
104. Noninvasive measurements of activity-induced changes in muscle metabolism
105. Reduced oxidative muscle metabolism in chronic fatigue syndrome
106. Calculated equilibria of phosphocreatine and adenosine phosphates during utilization of high energy phosphate by muscle
107. A linear model of muscle respiration explains monoexponential phosphocreatine changes
108. Phosphorus nuclear magnetic resonance of fast- and slow-twitch muscle
109. 31P nuclear magnetic resonance studies of high energy phosphates and pH in human muscle fatigue. Comparison of aerobic and anaerobic exercise
110. Factors which influence alterations of phosphates and pH in exercising human skeletal muscle: Measurement error, reproducibility, and effects of fasting, carbohydrate loading, and metabolic acidosis
111. Effects of fatiguing exercise on high-energy phosphates, force, and EMG: Evidence for three phases of recovery
112. Forearm metabolic asymmetry detected by 31P-NMR during submaximal exercise
113. Slower recovery of muscle phosphocreatine in malignant hyperthermia-susceptible individuals assessed by 31P-MR spectroscopy
114. Hypohydration effects on skeletal muscle performance and metabolism: A 31P-MRS study
115. P-31 magnetic resonance spectroscopy in polymyositis and dermatomyositis. Altered energy utilization during exercise
116. Nuclear magnetic resonance studies of forearm muscle in Duchenne dystrophy
117. Mitochondrial DNA deletions in inclusion body myositis
118. Non-invasive evaluation of malignant hyperthermia susceptibility with phosphorus nuclear magnetic resonance spectroscopy
119. Functional pools of oxidative and glycolyric fibers in human muscle observed by 31P magnetic resonance spectroscopy during exercise
120. Analysis of 31P MR spectroscopy data using artificial neural networks for longitudinal evaluation of muscle diseases: Dermatomyositis
121. Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis
122. Use of P-31 magnetic resonance spectroscopy to detect metabolic abnormalities in muscles of patients with fibromyalgia
123. Dermatomyositis correlative MR imaging and P-31 MR spectroscopy for quantitative characterization of inflammatory disease
124. Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis
125. Improved noninvasive diagnostic testing for malignant hyperthermia susceptibility from a combination of metabolites determined in vivo with 31P-magnetic resonance spectroscopy
126. Impairment of muscular metabolism in chronic respiratory failure. A human 31P MRS study
127. MELAS syndrome with mitochondrial tRNA(Leu)(UUR) mutation: Correlation of clinical state, nerve conduction, and muscle 31P magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin
128. 31P NMR examination of two patients with NADH-CoQ reductase deficiency
129. Energy metabolism of the gastrocnemius and soleus muscles during isometric voluntary and electrically induced contractions in man
130. In vivo functioning of creatine phosphokinase in human forearm muscle, studied by 31P NMR saturation transfer
131. Examination of a case of suspected McArdle's syndrome by 31P nuclear magnetic resonance
132. Effects of ovariectomy on energy metabolism in exercising rat muscle studied by 31P-NMR
133. Efficiency of human skeletal muscle in vivo: Comparison of isometric, concentric, and eccentric muscle action
134. Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: A study of 56 patients
135. Dissociation between metabolic and contractile response during intermittent isometric exercise in man
136. Dynamic phosphorus-31 magnetic resonance spectroscopy of the quadriceps muscle: Effects of age and sex on spectroscopic results
137. Lack of association between fibromyalgia syndrome and abnormalities in muscle energy metabolism
138. Study of fatigue in muscles of patients with post-polio syndrome by in vivo [31P]magnetic resonance spectroscopy. A metabolic cause for fatigue
139. Creatine supplementation and age influence muscle metabolism during exercise
140. Effects of aerobic training in patients with mitochondrial myopathies
141. Short-term aerobic training response in chronic myopathies
142. Control of the rate of phosphocreatine resynthesis after exercise in trained and untrained human quadriceps muscles
143. Relationships between fiber composition and NMR measurements in human skeletal muscle
144. Creatine monohydrate increases strength in patients with neuromuscular disease
145. Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease
146. Muscle phosphorus magnetic resonance spectroscopy oxidative indices correlate with physical activity
147. Bioenergetics of skeletal muscle in mitochondrial myopathy
148. Ageing: Effects on oxidative function of skeletal muscle in vivo
149. Skeletal muscle bioenergetics in myotonic dystrophy
150. Cellular energetics in hypothyroid muscle
151. Energetics of human muscle: Exercise-induced ATP depletion
152. 31P-nuclear magnetic resonance studies of bioenergetic changes in skeletal muscle in malnourished human adults
153. Uraemic muscle metabolism at rest and during exercise
154. Effect of creatine on aerobic and anaerobic metabolism in skeletal muscle in swimmers
155. Phosphocreatine resynthesis is not affected by creatine loading
156. Muscle phosphoglycerate mutase (PGAM) deficiency in the first Caucasian patient: Biochemistry, muscle culture and 31P-MR spectroscopy
157. Recovery of free ADP, Pi, and free energy of ATP hydrolysis in human skeletal muscle
158. Noninvasive measurement of phosphocreatine recovery kinetics in single human muscles
159. Creatine monohydrate in muscular dystrophies: A double blind, placebo-controlled clinical study
160. Metabolic response to exercise in malignant hyperthermia-sensitive patients measured by 31P magnetic resonance spectroscopy
161. Constant relationships between force, phosphate concentration, and pH in muscles with differential fatigability
162. Skeletal muscle metabolism in the chronic fatigue syndrome. In vivo assessment by 31P nuclear magnetic resonance spectroscopy
163. Effects of active and passive recoveries on splitting of the inorganic phosphate peak determined by 31P-nuclear magnetic resonance spectroscopy
164. 31P NMR studies in Duchenne muscular dystrophy: Age-related metabolic changes
165. Forearm P-31 nuclear magnetic resonance spectroscopy studies in oculopharyngeal muscular dystrophy
166. Metabolic changes in human muscle denervation: Topical 31P NMR spectroscopy studies